Prev Close | 122.00 |
Open | 121.75 |
Day Low/High | 121.15 / 122.26 |
52 Wk Low/High | 72.13 / 121.41 |
Volume | 4.36M |
Prev Close | 122.00 |
Open | 121.75 |
Day Low/High | 121.15 / 122.26 |
52 Wk Low/High | 72.13 / 121.41 |
Volume | 4.36M |
Exchange | NYSE |
Shares Outstanding | 1348.07B |
Market Cap | 162.65B |
P/E Ratio | 44.67 |
Div & Yield | N.A. (N.A) |
Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.
Their overseas business has been carrying them.
When it comes to AI solutions meant for specific industries, IBM has a lot of expertise and the ability to cast a broad net.
There are nearly too many surging sectors to count.
Four women serve on the boards of four S&P 500 companies at the same time.
You might want to review your holdings in the sector.
Here's how to use charts to trade five stocks, including Dow Chemical and Honeywell.
Dividend growers Texas Instruments, Accenture and Medtronic are superior to companies that simply sport high dividend yields, says one portfolio manager.
Just like cloud computing drove Amazon, AI should do the same for Big Blue.
There are some good ones today, but for different reasons.
But several airline and retail stocks are proving highly volatile.
Technology stocks dominate the bearish ledger this week.
Let me give you the unassailable themes.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Medtronic's $1.1 billion proposed acquisition of HeartWare International on Monday is a smart deal.
U.S. stocks extended their declines, piling on heavy losses suffered at the end of last week, as markets continued to react to the pro-exit vote from the U.K.
Medtronic is raising its quarterly dividend by 13 percent to $0.43 a share.
Shares of Medtronic rallied in Tuesday's trading session on the heels of the medical technology company's investor day meeting.
Somewhat dovish tones from Fed Chair Janet Yellen may help markets Tuesday.
David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.
Jim Cramer is bullish on Abbott Laboratories' acquisition of St. Jude Medical.
Stock is up some 14% YTD, but good news might already be priced in.
TheStreet’s Jim Cramer said Caterpillar is his top infrastructure play, and he also likes Vulcan Materials, and Martin Marietta Materials.